From Wikipedia, the free encyclopedia



Links

Users

Additions

  1. 2016-03-02 22:25:51 (UTC): User 12.233.231.178 t • c • dc • l • ef • b • bl; (18) to Cabozantinib ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2068953 ( R/ Xmeta/ L- removed)
    Other links: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2126057 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2126057 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2068953 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2068953 (18, 13, 8, 1- R/ X/ L)
  2. 2016-03-03 00:51:33 (UTC): User 76.108.74.132 t • c • dc • l • ef • b • bl; (25) to Kidney cancer ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 ( R/ Xmeta/ L- removed)
    Other links: www.nccn.org/disclosures/MinuteHandler.ashx?fileManagerId=280 (25, 311, 4, 0- R/ X/ L) www.nccn.org/disclosures/MinuteHandler.ashx?fileManagerId=280 (25, 311, 4, 0- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (25, 13, 2, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (25, 13, 2, 1- R/ X/ L) www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473971.htm (25, -1, X, X- R/ X/ L) www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473971.htm (25, -1, X, X- R/ X/ L)
  3. 2016-03-03 14:21:35 (UTC): User 12.233.231.178 t • c • dc • l • ef • b • bl; (18) to Kidney cancer ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 ( R/ Xmeta/ L- removed)
    Other links: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L)
  4. 2019-12-04 18:41:18 (UTC): User 2607:FB60:1011:2006:91A8:1A24:9327:7E27 t • c • dc • l • ef • b • bl; (4) to Alan Garber ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/news-releases/news-release-details/exelixis-appoints-dr-alan-m-garber-board-directors ( R/ Xmeta/ L- still there)
    Other links: wallmine.com/people/9097/alan-m-garber (4, 94, 1, 1- R/ X/ L) www.thecrimson.com/article/2019/10/24/garber-pharmaceutical-companies/ (4, 9071, X, X- R/ X/ L) investors.vrtx.com/news-releases/news-release-details/vertex-names-dr-alan-garber-provost-harvard-university-its-board (4, 34, 1, 1- R/ X/ L) ir.exelixis.com/news-releases/news-release-details/exelixis-appoints-dr-alan-m-garber-board-directors (4, 13, 1, 1- R/ X/ L)
  5. 2020-12-13 15:19:42 (UTC): User 103.155.67.36 t • c • dc • l • ef • b • bl; (63) to Exelixis ( | talk | history | links | watch | logs) ( diff  top) - Link: ir.exelixis.com/news-releases/news-release-details/exelixis-announces-fourth-quarter-and-full-year-2019-financial#:~:text=In%202019%2C%20global%20cabozantinib%20franchise,time%20in%20a%20calendar%20year ( R/ Xmeta/ L- still there)
    Other links: ir.exelixis.com/news-releases/news-release-details/exelixis-announces-fourth-quarter-and-full-year-2019-financial#:~:text=In%202019%2C%20global%20cabozantinib%20franchise,time%20in%20a%20calendar%20year (63, 13, 2, 1- R/ X/ L) ir.exelixis.com/news-releases/news-release-details/exelixis-announces-fourth-quarter-and-full-year-2019-financial#:~:text=In%202019%2C%20global%20cabozantinib%20franchise,time%20in%20a%20calendar%20year (63, 13, 2, 1- R/ X/ L)
  • Displayed all 5 additions.
From Wikipedia, the free encyclopedia



Links

Users

Additions

  1. 2016-03-02 22:25:51 (UTC): User 12.233.231.178 t • c • dc • l • ef • b • bl; (18) to Cabozantinib ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2068953 ( R/ Xmeta/ L- removed)
    Other links: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2126057 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2126057 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2068953 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2068953 (18, 13, 8, 1- R/ X/ L)
  2. 2016-03-03 00:51:33 (UTC): User 76.108.74.132 t • c • dc • l • ef • b • bl; (25) to Kidney cancer ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 ( R/ Xmeta/ L- removed)
    Other links: www.nccn.org/disclosures/MinuteHandler.ashx?fileManagerId=280 (25, 311, 4, 0- R/ X/ L) www.nccn.org/disclosures/MinuteHandler.ashx?fileManagerId=280 (25, 311, 4, 0- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (25, 13, 2, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (25, 13, 2, 1- R/ X/ L) www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473971.htm (25, -1, X, X- R/ X/ L) www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473971.htm (25, -1, X, X- R/ X/ L)
  3. 2016-03-03 14:21:35 (UTC): User 12.233.231.178 t • c • dc • l • ef • b • bl; (18) to Kidney cancer ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 ( R/ Xmeta/ L- removed)
    Other links: ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L) ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID=2133957 (18, 13, 8, 1- R/ X/ L)
  4. 2019-12-04 18:41:18 (UTC): User 2607:FB60:1011:2006:91A8:1A24:9327:7E27 t • c • dc • l • ef • b • bl; (4) to Alan Garber ( | talk | history | links | watch | logs) ( diff  !top) - Link: ir.exelixis.com/news-releases/news-release-details/exelixis-appoints-dr-alan-m-garber-board-directors ( R/ Xmeta/ L- still there)
    Other links: wallmine.com/people/9097/alan-m-garber (4, 94, 1, 1- R/ X/ L) www.thecrimson.com/article/2019/10/24/garber-pharmaceutical-companies/ (4, 9071, X, X- R/ X/ L) investors.vrtx.com/news-releases/news-release-details/vertex-names-dr-alan-garber-provost-harvard-university-its-board (4, 34, 1, 1- R/ X/ L) ir.exelixis.com/news-releases/news-release-details/exelixis-appoints-dr-alan-m-garber-board-directors (4, 13, 1, 1- R/ X/ L)
  5. 2020-12-13 15:19:42 (UTC): User 103.155.67.36 t • c • dc • l • ef • b • bl; (63) to Exelixis ( | talk | history | links | watch | logs) ( diff  top) - Link: ir.exelixis.com/news-releases/news-release-details/exelixis-announces-fourth-quarter-and-full-year-2019-financial#:~:text=In%202019%2C%20global%20cabozantinib%20franchise,time%20in%20a%20calendar%20year ( R/ Xmeta/ L- still there)
    Other links: ir.exelixis.com/news-releases/news-release-details/exelixis-announces-fourth-quarter-and-full-year-2019-financial#:~:text=In%202019%2C%20global%20cabozantinib%20franchise,time%20in%20a%20calendar%20year (63, 13, 2, 1- R/ X/ L) ir.exelixis.com/news-releases/news-release-details/exelixis-announces-fourth-quarter-and-full-year-2019-financial#:~:text=In%202019%2C%20global%20cabozantinib%20franchise,time%20in%20a%20calendar%20year (63, 13, 2, 1- R/ X/ L)
  • Displayed all 5 additions.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook